Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents

Abstract

Background: Antineoplastic agents represent the most common class of drugs causing Adverse Drug Reactions (ADRs). Mutant alleles of genes coding for drug-metabolizing enzymes are the best studied individual risk factors for these ADRs. Although the correlation between genetic polymorphisms and ADRs is well-known, pharmacogenetic tests are limited to centralized laboratories with expensive or dedicated instrumentation used by specialized personnel. Nowadays, DNA chips have overcome the major limitations in terms of sensibility, specificity or small molecular detection, allowing the simultaneous detection of several genetic polymorphisms with time and costs-effective advantages. In this work, we describe the design of a novel silicon-based lab-on-chip assay able to perform low-density and high-resolution multi-assay analysis (amplification and hybridization reactions) on the In-Check platform. Methods: The novel lab-on-chip was used to screen 17 allelic variants of three genes associated with adverse reactions to common chemotherapeutic agents: DPYD (Dihydropyrimidine dehydrogenase), MTHFR (5,10-Methylenetetrahydrofolate reductase) and TPMT (Thiopurine S-methyltransferase). Results: Inter- and intra assay variability were performed to assess the specificity and sensibility of the chip. Linear regression was used to assess the optimal hybridization temperature set at 52 °C (R2 ≈ 0.97). Limit of detection was 50 nM. Conclusions: The high performance in terms of sensibility and specificity of this lab-on-chip supports its further translation to clinical diagnostics, where it may effectively promote precision medicine.

Thin-Film-Based Multifunctional System for Optical Detection and Thermal Treatment of Biological Samples

“…Portability, quick response time, and low reagents consumption are just some of the Lab-on-Chip (LoC) advantages that have led this technology to be among the major research focus of many academic and industrial groups over the last two decades [ 1 , 2 , 3 , 4 , 5 ]. The applications that can be developed by using LoC-based systems cover several research fields, starting from environment monitoring [ 6 , 7 , 8 ] toward health care and biomedical applications for disease detection and treatment [ 9 , 10 , 11 , 12 , 13 ].…”

Assessment and Management Pattern of Chemotherapeutic Drug Induced Adverse Effects among Cancer Patients at Tertiary Care Centre

“…These drugs are having a narrow therapeutic index and show dose-related inter-individual effects due to their variation in metabolism [5]. Among all treatment modalities, chemotherapy still represents a center of pharmacological strategy for different types of solid cancer treatments and improves patient conditions [6]. The chemotherapeutic drug produces toxicity as an extension of their therapeutic action and may hamper the patient quality of life by producing numerous adverse effects [7].…”

Microfluidic Bio-Sensors and Their Applications

“…One of the research articles presents integrated microfluidic sensors for rapid analyte detection on antibody-decorated beads for two acute kidney injury biomarkers [ 5 ]. A novel silicon-based lab-on-chip sensor to perform low-density and high-resolution multi-assay analysis for DNA amplification and hybridization is also presented to complement this Special Issue [ 6 ]. In the study ‘Surfactant-Based Microdroplets and Monitoring Bacterial Gas Metabolism with Droplet-Based Microfluidics’, the authors confirmed that gas cross reaction took place between droplets formed by fluorinated oil and the PFPE–PEG–PFPE surfactant [ 7 ].…”